MERRILL LYNCH & CO INC
S-3, 1997-09-29
SECURITY BROKERS, DEALERS & FLOTATION COMPANIES
Previous: MERRILL LYNCH & CO INC, 8-K, 1997-09-29
Next: MISSISSIPPI CHEMICAL CORP /MS/, 10-K, 1997-09-29



<PAGE>

    As filed with the Securities and Exchange Commission on September 29, 1997
                                                         Registration No. 333-
- ------------------------------------------------------------------------------
- ------------------------------------------------------------------------------

                        SECURITIES AND EXCHANGE COMMISSION
                              Washington, D.C. 20549
                                                   
                                    -----------

                                     FORM S-3
                              Registration Statement
                                       under
                            THE SECURITIES ACT OF 1933
                                                  
                                    -----------
     
                             MERRILL LYNCH & CO., INC.
              (Exact name of registrant as specified in its charter)
             DELAWARE                                  13-2740599
   (State or other jurisdiction           (I.R.S. Employer Identification No.)
of incorporation or organization)

                              World Financial Center
                                    North Tower
                           New York, New York 10281-1334
                                  (212) 449-1000
    (Address, including zip code, and telephone number, including area code, of
                      registrant's principal executive offices)

                                    -----------

                               MARK B. GOLDFUS, ESQ.
                             Associate General Counsel
                             Merrill Lynch & Co., Inc.
                              World Financial Center
                                    North Tower
                           New York, New York 10281-1334
                                  (212) 449-2827
           (Name, address, including zip code, and telephone number, 
                   including area code, of agent for service)
                                         
Approximate date of commencement of the proposed sale to the public:  From time
to time after the effective date of this Registration Statement, in connection
with resales of common stock described herein.

If the only securities being registered on this Form are being offered pursuant
to dividend or interest reinvestment plans, please check the following box. [  ]
If any of the securities being registered on this Form are to be offered on a
delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, other than securities offered only in connection with dividend or interest
reinvestment plans, check the following box. [X]
If this Form is filed to register additional securities for an offering pursuant
to Rule 426(b) under the Securities Act, please check the following box and list
the Securities Act registration statement number of the earlier effective
registration statement for the same offering. [  ] _______________
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under
the Securities Act, check the following box and list the Securities Act
registration number of the earlier effective registration statement for the same
offering. [  ] ________________
If delivery of the prospectus is expected to be made pursuant to Rule 434, 
please check the following box. [  ]

                                               CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION>
                                         
- --------------------------------------------------------------------------------------------------------------------------------
<S>                             <C>              <C>                          <C>                              <C>
Title of securities              Amount to      Proposed maximum offering     Proposed maximum aggregate          Amount of
 to be registered              be registered        price per share                 offering price           registration fee(2)
- --------------------------------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------------------------------
Common Stock, par value
$1.33-1/3 per share,
(including Preferred Stock
Purchase Rights)(1)..........4,600,000 shares           $71.3125                     $328,037,500                $99,405.30
- --------------------------------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------------------------------
</TABLE>

(1)  Prior to the occurrence of certain events, the Preferred Stock Purchase
     Rights will not be evidenced separately from the Common Stock; value 
     attributable to such Rights, if any, is reflected in the market price of 
     the Common Stock.
(2)  Calculated in accordance with Rule 457(c).
                                         
The Registrant hereby amends this Registration Statement on such date or 
dates as may be necessary to delay its effective date until the Registrant 
shall file a further amendment which specifically states that this 
Registration Statement shall thereafter become effective in accordance with 
Section 8(a) of the Securities Act of 1933 or until this Registration 
Statement shall become effective on such date as the Commission, acting 
pursuant to said Section 8(a), may determine.
- -----------------------------------------------------------------------------
- -----------------------------------------------------------------------------
 
<PAGE>

PROSPECTUS
                                         
                                         
                                         
                                         
                                 4,600,000 Shares
                                         
                             MERRILL LYNCH & CO., INC.
                                         
                                   Common Stock
                                         
                                   _____________
                                         
This Prospectus relates to the resale of up to 4,600,000 per shares  (the 
"Shares") of Common Stock, par value $1.33-1/3 per share ("Common Stock"), of 
Merrill Lynch & Co., Inc. (the "Company"), by the former owners of Hotchkis 
and Wiley L.P. ("Selling Shareholders") which are to be issued under the 
terms of the purchase agreement dated June 19, 1996 (the "Purchase 
Agreement") pursuant to which Merrill Lynch acquired Hotchkis and Wiley in 
November 1996. See "Selling Shareholders", "Plan of Distribution", and "Use 
of Proceeds".

The Shares will not be offered through an underwriter.  The Selling 
Shareholders have advised the Company that they intend to sell their Shares 
by means of ordinary broker's transactions or block trades on the New York 
Stock Exchange or any other exchange on which the Common Stock of the Company 
is listed from time to time, in the over-the-counter market or in private 
sales, at market prices prevailing at the time of such sales or negotiated 
prices and that selling brokers will be paid usual and customary commissions. 
 All expenses relating to the registration and listing of the Shares are 
being borne by the Company, but the brokerage commissions and other expenses 
of sale incurred by a Selling Shareholder will be borne by such Selling 
Shareholder.

                                   _____________


THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND 
EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION NOR HAS THE COMMISSION 
OR ANY STATE SECURITIES COMMISSION PASSED UPON THE ACCURACY OR ADEQUACY OF 
THIS PROSPECTUS.  ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

                                   _____________


No person is authorized to give any information or to make any 
representations other than those contained in this Prospectus, and if given 
or made such information or representations must not be relied upon as having 
been authorized. This Prospectus does not constitute an offer to sell or a 
solicitation of an offer to buy any of these securities in any jurisdiction 
to any person to whom it is unlawful to make such offer or solicitation in 
such jurisdiction.
                                         
                                   _____________
                                         
                                         
                                         
                                         
                                         
                                         
                                         
                                         
                                         
                The date of this Prospectus is September   , 1997.
                                          

<PAGE>

                                 TABLE OF CONTENTS
                                                                      Page
    Available Information...........................................    2
    Incorporation of Certain Documents by Reference.................    2
    Merrill Lynch & Co., Inc. ......................................    3
    Use of Proceeds.................................................    3
    Selling Shareholders............................................    4
    Plan of Distribution............................................    5
    Description of Common Stock.....................................    5
    Experts.........................................................    5
                                         
                               AVAILABLE INFORMATION
                                         
    The Company is subject to the reporting requirements of the Securities 
Exchange Act of 1934 (the "Exchange Act") and, in accordance therewith, files 
reports and other information with the Securities and Exchange Commission 
(the "Commission").  Reports, proxy statements, and other information filed 
by the Company can be inspected and copied at the public reference facilities 
maintained by the Commission at Room 1024, 450 Fifth Street, N.W., 
Washington, D.C. 20549, as well as the following Regional Offices of the 
Commission: Midwest Regional Office, 500 West Madison Street, Suite 1400, 
Chicago, Illinois 60661-2551 and Northeast Regional Office, Seven World Trade 
Center, New York, New York 10048. Copies of such material can also be 
obtained from the Public Reference Section of the Commission at 450 Fifth 
Street, N.W., Washington, D.C. 20549 at prescribed rates.  Reports, proxy 
statements, and other information concerning the Company may also be 
inspected at the offices of the New York Stock Exchange, the American Stock 
Exchange, the Chicago Stock Exchange, and the Pacific Stock Exchange.  The 
Commission maintains a Web site at http://www.sec.gov containing reports, 
proxy and information statements and other information regarding registrants, 
including the Company, that file electronically with the Commission.

                  INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE
                                         
    The Company's Annual Report on Form 10-K for the year ended December 27, 
1996, Quarterly Reports on Form 10-Q for the quarters ended March 28, 1997 
and June 27, 1997, and Current Reports on Form 8-K dated January 13, 1997, 
January 27, 1997, February 25, 1997, March 14, 1997, April 15, 1997, May 2, 
1997, May 30, 1997, June 3, 1997, July 16, 1997, July 30, 1997, August 1, 
1997, September 24, 1997, and September 29, 1997, filed pursuant to
Section 13 of the Exchange Act, are incorporated by reference herein.

    All documents filed by the Company pursuant to Sections 13(a), 13(c), 14 
or 15(d) of the Exchange Act subsequent to the date hereof and prior to the 
termination of the offering of the securities registered hereunder shall be 
deemed to be incorporated by reference herein and to be part hereof from the 
date of filing of such documents.  Any statement contained in a document 
incorporated or deemed to be incorporated by reference herein shall be deemed 
to be modified or superseded for purposes hereof to the extent that a 
statement contained herein or in any other subsequently filed document which 
also is or is deemed to be incorporated by reference herein modifies or 
supersedes such statement.  Any such statement so modified or superseded 
shall not be deemed, except as so modified or superseded, to constitute a 
part hereof.

    The Company will provide without charge to each person to whom this 
Prospectus is delivered, on the written or oral request of any such person 
(without exhibits other than exhibits specifically incorporated by reference) 
of any or all of the documents incorporated by reference in this Prospectus. 
Requests for such copies may be directed to Lawrence M. Egan, Jr., Assistant 
Secretary, Merrill Lynch & Co., Inc., 100 Church Street, 12th Floor, New 
York, New York 10080-6512 (telephone number: (212) 602-8435).
                                          
                                         2
<PAGE>

                             MERRILL LYNCH & CO., INC.
                                         
    Merrill Lynch & Co., Inc. is a holding company that, through its 
subsidiaries and affiliates, provides investment, financing, insurance, and 
related services on a global basis.  Its principal subsidiary, Merrill Lynch, 
Pierce, Fenner & Smith Incorporated ("MLPF&S"), one of the largest securities 
firms in the world, is a leading broker in securities, options contracts and 
commodity and financial futures contracts; a leading dealer in options and in 
corporate and municipal securities; a leading investment banking firm that 
provides advice to, and raises capital for, its clients; and an underwriter 
of selected insurance products.  Other subsidiaries provide financial 
services on a global basis similar to those of MLPF&S and are engaged in such 
other activities as international banking, lending, and providing other 
investment and financing services.  Merrill Lynch International Incorporated, 
through subsidiaries and affiliates, provides investment, financing, and 
related services outside the United States and Canada.  Merrill Lynch Asset 
Management, LP and Fund Asset Management, LP together constitute one of the 
largest mutual fund managers in the world and provide investment advisory 
services.  Merrill Lynch Government Securities Inc. is a primary dealer in 
obligations issued or guaranteed by the U.S. Government and its agencies.  
Merrill Lynch Capital Services, Inc., Merrill Lynch Derivative Products AG, 
and Merrill Lynch International are the Company's primary derivative product 
dealers and enter into interest rate and currency swaps and other derivative 
transactions as intermediaries and as principals.  The Company's insurance 
underwriting operations consist of the underwriting of life insurance and 
annuity products.  Banking, trust, and mortgage lending operations conducted 
through subsidiaries of the Company include issuing certificates of deposit, 
offering money market deposit accounts, making secured loans, and providing 
foreign exchange trading facilities and other related services.

    The principal executive office of the Company is located at World 
Financial Center, North Tower, 250 Vesey Street, New York, New York  10281; 
its telephone number is (212) 449-1000.

                                  USE OF PROCEEDS
                                         
    The net proceeds to the Selling Shareholders from the sale of the Shares 
will be the proceeds of sale less any brokerage commissions paid by the 
Selling Shareholders.  The Company will receive no part of the proceeds from 
the sale of the Shares offered hereby.





                                         3              
<PAGE>

                              SELLING SHAREHOLDERS
                                         
    All of the Selling Shareholders are former equity owners of Hotchkis and 
Wiley L.P. or related parties.  Pursuant to the Purchase Agreement, and 
subject to the terms and conditions set forth therein, the Selling 
Shareholders will receive Shares in annual installments, with the first 
installment payable on November 12, 1997 and the final installment payable on 
November 12, 1999, in the case of Messrs. Hotchkis and Wiley, and on November 
12, 2003, in the case of Ms. Bardin and Messrs. Baxter, Davis and DeBard.   
The exact number of shares payable to each Selling Shareholder will be 
determined at the time of payment based upon a formula contained in the 
Purchase Agreement.

    The table below sets forth, for each of the Selling Shareholders, the 
Selling Shareholder's affiliation with the Company and the aggregate number 
of shares of Common Stock owned by each Selling Shareholder prior to the 
offering made hereby: 

- ------------------------------------------------------------------------------
                                                      Number of shares of 
  Selling                                         Common Stock beneficially
Shareholder         Affiliation with Company   owned prior to this offering(1)
- ------------------------------------------------------------------------------
George Wiley (2)    Special Assistant to the
                       Company's Capital
                    Management Group ("CMG")                    0

John F. Hotchkis    Chairman of the Hotchkis
                   and Wiley Division of CMG                  710

Gail Bardin         Managing Director - CMG                   236

Michael F. Baxter   Managing Director - CMG                   286

George Davis        Managing Director - CMG                   236

Roger DeBard        Managing Director - CMG                   315
- ------------------------------------------------------------------------------

    The number of Shares to be received by each Selling Shareholder pursuant 
to the Purchase Agreement and the maximum number of Shares that may be sold 
by each Selling Shareholder pursuant to this Prospectus are not currently 
determinable, but the aggregate number of Shares sold pursuant to this 
Prospectus will not exceed 4,600,000.  Assuming all such Shares are sold 
pursuant to this Prospectus, the amount of Common Stock beneficially owned by 
the Selling Shareholders as of September 1, 1997, which represents in each 
case less than 1% of the outstanding Common Stock, will be unaffected.  There 
can be no assurance, however, that the Selling Shareholders will sell all or 
any portion of the Shares that may be offered hereunder.






(1)   As of  September 1, 1997.

(2)  Reference to, and information concerning, George Wiley includes the 
following related parties:  George Wiley Inc., a California corporation, and 
Marilyn M. Wiley, his spouse, as trustee for various testamentary trusts.


                                       4
<PAGE> 

                             PLAN OF DISTRIBUTION
                                         
  The Shares will not be offered through an underwriter.  The Selling 
Shareholders have advised the Company that they intend to sell their Shares 
by means of ordinary broker's transactions or block trades on the New York 
Stock Exchange or any other exchange on which the Common Stock is listed from 
time to time, in the over-the-counter market or in private sales, at market 
prices prevailing at the time of such sales or negotiated prices and that 
selling brokers will be paid usual and customary commissions.  All expenses 
relating to the registration and listing of the Shares are being borne by the 
Company, but the brokerage commissions and other expenses of sale incurred by 
a Selling Shareholder will be borne by such Selling Shareholder.

                            DESCRIPTION OF COMMON STOCK
                                         
  The authorized capital stock of the Company consists of 500,000,000 shares 
of Common Stock and 25,000,000 shares of preferred stock, par value $1.00 per 
share, issuable in series ("Preferred Stock").  The holders of shares of 
Common Stock are entitled to one vote for each share held and each share of 
Common Stock is entitled to participate equally in dividends out of funds 
legally available therefor, as and when declared by the Board of Directors, 
and in the distribution of assets in the event of liquidation.  The shares of 
Common Stock have no preemptive or conversion rights, redemption provisions 
or sinking fund provisions.  The outstanding shares of Common Stock are, and 
the Shares offered hereby will be, duly and validly issued, fully paid and 
nonassessable.  Each share is eligible to participate under the Rights 
Agreement referenced below and, to the extent specified therein, to purchase 
certain securities upon the occurrence of certain events specified in the 
Rights Agreement.

  The Board of Directors of the Company, without further action by 
stockholders, has the authority, to issue shares of Preferred Stock from time 
to time in one or more series and to fix the powers (including voting power), 
designations, preferences as to dividends and liquidation, and relative, 
participating, optional, or other special rights and the qualifications, 
limitations, or restrictions thereof.  As of June 27, 1997, there were 
17,000,000 Depositary Shares issued, each representing a one four-hundredth 
interest in a share of the Company's 9% Cumulative Preferred Stock, Series A 
(the "9% Preferred Stock"). The 9% Preferred Stock is a single series 
consisting of 42,500 shares with an aggregate liquidation preference of 
$425,000,000.  As of June 27, 1997, there were 42,500 shares of 9% Preferred 
Stock outstanding.  From time to time, MLPF&S may occasionally acquire a 
temporary position in the Depositary Shares.  As of June 27, 1997, the 
Depositary Shares held by MLPF&S for the purpose of resale was not material.  
The 9% Preferred Stock has dividend and liquidation preference over the 
Common Stock and over the Series A Junior Preferred Stock issuable pursuant 
to a Rights Agreement dated as of December 16, 1987 between ML & Co. and The 
Chase Manhattan Bank (successor by merger to Manufacturers Hanover Trust 
Company).

                                      EXPERTS
                                         
  The consolidated financial statements and related financial statement 
schedules of the Company and its subsidiaries included or incorporated by 
reference in the Company's 1996 Annual Report on Form 10-K, and incorporated 
by reference in this Prospectus, have been audited by Deloitte & Touche LLP, 
independent auditors, as stated in their reports incorporated by reference 
herein.  The Selected Financial Data under the captions "Operating Results", 
"Financial Position" and "Common Share Data" for each of the five years in 
the period ended December 27, 1996 included in the 1996 Annual Report to 
Stockholders of the Company, and incorporated by reference herein, have been 
derived from consolidated financial statements audited by Deloitte & Touche 
LLP, as set forth in their reports incorporated by reference herein.  Such 
consolidated financial statements and related financial statement schedules, 
and such Selected Financial Data incorporated by reference in this Prospectus 
and the Registration Statement of which this Prospectus is a part, have been 
incorporated herein by reference in reliance upon such reports of Deloitte & 
Touche LLP given upon their authority as experts in accounting and auditing.



                                     5
<PAGE>

  With respect to unaudited interim financial information for the periods 
included in the Quarterly Reports on Form 10-Q which are incorporated herein 
by reference, Deloitte & Touche LLP have applied limited procedures in 
accordance with professional standards for a review of such information.  
However, as stated in their reports included in such Quarterly Reports on 
Form 10-Q and incorporated by reference herein, they did not audit and they 
do not express an opinion on such interim financial information.  
Accordingly, the degree of reliance on their reports on such information 
should be restricted in light of the limited nature of the review procedures 
applied.  Deloitte & Touche LLP are not subject to the liability provisions 
of Section 11 of the Securities Act of 1933, as amended (the "Securities 
Act") for any such report on unaudited interim financial information because 
any such report is not a "report" or a "part" of the registration statement 
prepared or certified by an accountant within the meaning of Sections 7 and 
11 of the Securities Act. 






                                        6
<PAGE>
                                     PART II
                                         
                      INFORMATION NOT REQUIRED IN PROSPECTUS
                                         



Item 14.  Other Expenses of Issuance and Distribution.

  The following table sets forth all expenses in connection with the issuance 
and distribution of the securities being registered, all of which are payable 
by the Company.  All the amounts shown are estimates, except the registration 
fee.

           Registration fee                             $99,405
           Fees and expenses of accountants               3,000
           Fees and expenses of counsel                   2,500
           Printing expenses                              1,000
           Miscellaneous                                  3,000
                                                       --------
                    Total                              $108,905
                                                       --------
                                                       --------

Item 15.  Indemnification of Directors and Officers.

  Section 145 of the General Corporation Law of the State of Delaware, as 
amended, provides that under certain circumstances a corporation may 
indemnify any person who was or is a party or is threatened to be made a 
party to any threatened, pending or completed action, suit or proceeding 
whether civil, criminal, administrative or investigative, by reason of the 
fact that he is or was a director, officer, employee or agent of the Company 
or is or was serving at its request in such capacity in another corporation 
or business association, against expenses (including attorneys' fees), 
judgments, fines and amounts paid in settlement actually and reasonably 
incurred by him in connection with such action, suit or proceeding if he 
acted in good faith and in a manner he reasonably believed to be in or not 
opposed to the best interests of the Company and, with respect to any 
criminal action or proceeding, had no reasonable cause to believe his conduct 
was unlawful.

  Article XIII, Section 2 of the Restated Certificate of Incorporation of the 
Company provides in effect that, subject to certain limited exceptions, the 
Company shall indemnify its directors and officers to the extent authorized 
or permitted by the General Corporation Law of the State of Delaware.  The 
directors and officers of the Company are insured under policies of insurance 
maintained by the Company, subject to the limits of the policies, against 
certain losses arising from any claims made against them by reason of being 
or having been such directors or officers.  In addition, the Company has 
entered into contracts with all of its directors providing for 
indemnification of such persons by the Company to the full extent authorized 
or permitted by law, subject to certain limited exceptions.



                                   II-1
<PAGE> 

Item 16.  Exhibits.

      4(a)    Restated Certificate of Incorporation of the Company, as amended
              April 24, 1987 (incorporated by reference to Exhibit 3(i) to the
              Company's Annual Report on Form 10-K for the fiscal year ended
              December 25, 1992 ("1992 10-K") (File No. 1-7182)).
      4(b)    Certificate of Amendment, dated April 29, 1993, of the
              Certificate of Incorporation of the Company (incorporated by 
              reference to Exhibit 3(i) to the Company's Quarterly Report on
              Form 10-Q for the quarter ended March 26, 1993 (File No. 1-7182)).
      4(c)    By-Laws of the Company, effective as of April 15, 1997 
              (incorporated by reference to Exhibit 3(ii) to the Company's 
              Quarterly Report on Form 10-Q for the quarter ended March 28, 1997
              (File No. 1-7182)).
      4(d)    Form of Rights Agreement, dated as of December 16, 1987, between
              the Company and The Chase Manhattan Bank (successor by merger to
              Manufacturers Hanover Trust Company) (incorporated by reference 
              to Exhibit 3(iv) to the 1992 10-K).
      4(e)    Certificate of Designation of the Company establishing the rights,
              preferences, privileges, qualifications, restrictions and 
              limitations relating to the Company's 9% Cumulative Preferred
              Stock, Series A (incorporated by reference to Exhibit 4(iii) to
              the Company's Quarterly Report on Form 10-Q for the quarter ended
              September 30, 1994 (File No. 1-7182)).
      4(f)    Certificate of Designation of the Company establishing the rights,
              preferences, privileges, qualifications, restrictions and 
              limitations relating to the Company's Series A Junior Preferred
              Stock (incorporated by reference to Exhibit 3(f) to the Company's
              Registration Statement on Form S-3 (File No. 33-19975)).
    + 5       Opinion of Counsel.
    +15       Letter re: unaudited interim financial information.
    +23(a)    Consent of Counsel (included as part of Exhibit 5).
    +23(b)    Consent of Deloitte & Touche LLP.
     24       Power of Attorney (included on Page II-4).

    + Filed herewith.

Item 17.  Undertakings.

  The undersigned registrant hereby undertakes:

  (a)(1) To file, during any period in which offers or sales are being made, a
post-effective amendment to this registration statement:

        (i)   To include any prospectus required by Section 10(a)(3) of the
  Securities Act of 1933;

        (ii)  To reflect in the prospectus any facts or events arising after
  the effective date of the registration statement (or the most recent
  post-effective amendment thereof) which, individually or in the aggregate,
  represent a fundamental change in the information set forth in the 
  registration statement;

        (iii) To include any material information with respect to the plan of
  distribution not previously disclosed in the registration statement or any
  material change to such information in the registration statement;

provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if 
the registration statement is on Form S-3 and the information required to be 
included in a post-effective amendment by those paragraphs is contained in 
periodic reports filed by the registrant pursuant to Section 13 or 15(d) of 
the Securities Exchange Act of 1934 that are incorporated by reference in the 
registration statement.

  (2)    That, for the purpose of determining any liability under the 
Securities Act of 1933, each such post-effective amendment shall be deemed to 
be a new registration statement relating to the securities offered therein, 
and the offering of such securities at the time shall be deemed to be the 
initial bona fide offering thereof.


                                       II-2
<PAGE>

  (3)    To remove from registration by means of a post-effective amendment 
any of the securities being registered which remain unsold at the termination 
of the offering.

  (b)    That, for the purpose of determining any liability under the 
Securities Act of 1933, each filing of the registrant's annual report 
pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 
that is incorporated by reference in this registration statement shall be 
deemed to be a new registration statement relating to the securities offered 
herein, and the offering of such securities at the time shall be deemed to be 
the initial bona fide offering thereof.

  (c)    Insofar as indemnification for liabilities arising under the 
Securities Act of 1933 may be permitted to directors, officers and 
controlling persons of the registrant pursuant to the provisions referred to 
in Item 15 of this registration statement, or otherwise, the registrant has 
been advised that in the opinion of the Securities and Exchange Commission 
such indemnification is against public policy as expressed in the Act and is, 
therefore, unenforceable.  In the event that a claim for indemnification 
against such liabilities (other than the payment by the registrant of 
expenses incurred or paid by a director, officer or controlling person of the 
registrant in the successful defense of any action, suit or proceeding) is 
asserted by such director, officer or controlling person in connection with 
the securities being registered, the registrant will, unless in the opinion 
of its counsel the matter has been settled by controlling precedent, submit 
to a court of appropriate jurisdiction the question whether such 
indemnification by the registrant is against public policy as expressed in 
the Act and will be governed by the final adjudication of such issue.
 



                                         II-3
<PAGE>

                                     SIGNATURES
                                         
  Pursuant to the requirements of the Securities Act of 1933, the Company
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-3 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in The City of New York and State of New York on the 29th day of
September, 1997.



                                             MERRILL LYNCH & CO., INC.



                                             By: /s/ David H. Komansky
                                               -------------------------------
                                                      David H. Komansky
                                                   (Chairman of the Board,
                                                    Chief Executive Officer 
                                                    and Director)

  KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears 
below constitutes and appoints David H. Komansky, Joseph T. Willett and 
Stephen L. Hammerman, and each of them, his true and lawful attorneys-in-fact 
and agents, with full power of substitution and resubstitution, for him and 
in his name, place and stead, in any and all capacities, to sign any and all 
amendments (including post-effective amendments) to this Registration 
Statement, and to file the same, with all exhibits thereto and other 
documents in connection therewith, with the Securities and Exchange 
Commission, granting unto said attorneys-in-fact and agents, and each of 
them, full power and authority to do and perform each and every act and thing 
requisite and necessary to be done in and about the premises, as fully to all 
intents and purposes as he might or could do in person hereby ratifying and 
confirming all that said attorneys-in-fact and agents or any of them, or 
their or his substitute or substitutes, may lawfully do or cause to be done 
by virtue thereof.

  Pursuant to the requirements of the Securities Act of 1933, this 
Registration Statement has been signed below by the following persons in the 
capacities indicated on the 29th day of September, 1997.

               Signature                                 Title
               ---------                                 -----


        /s/ David H. Komansky                Chairman of the Board, Chief
- ------------------------------------        Executive Officer and Director
        (David H. Komansky)



     /s/ Herbert M. Allison, Jr.              President, Chief Operating
- -----------------------------------              Officer and Director
      (Herbert M. Allison, Jr.)



       /s/ Joseph T. Willett                    Senior Vice President
- ----------------------------------       Chief Financial Officer (Principal
        (Joseph T. Willett)                       Financial Officer)



     /s/ Michael J. Castellano          Senior Vice President and Controller
- ---------------------------------            (Principal Accounting Officer)
      (Michael J. Castellano)   



                                     II-4
<PAGE>

            Signature                             Title
            ---------                             -----


    /s/ William O. Bourke
- ---------------------------------                Director
     (William O. Bourke)



       /s/ W.H. Clark
- ---------------------------------                Director
        (W.H. Clark)



     /s/ Jill K. Conway
- ---------------------------------                Director
      (Jill K. Conway)



  /s/ Stephen L. Hammerman
- ---------------------------------                Director
   (Stephen L. Hammerman)



  /s/ Earle H. Harbison, Jr.
- ---------------------------------                Director
   (Earle H. Harbison, Jr.)



     /s/ George B. Harvey
- ---------------------------------                Director
      (George B. Harvey)



    /s/ William R. Hoover
- ---------------------------------                Director
     (William R. Hoover)



    /s/ Robert P. Luciano
- ---------------------------------                Director
     (Robert P. Luciano)



   /s/ David K. Newbigging
- ---------------------------------                Director
     (David K. Newbigging)



     /s/ Aulana L. Peters
- ---------------------------------                Director
      (Aulana L. Peters)



    /s/ John J. Phelan, Jr.
- ---------------------------------                Director
     (John J. Phelan, Jr.)



     /s/ John L. Steffens
- ---------------------------------                Director
       (John L. Steffens)



     /s/ William L. Weiss
- ---------------------------------                Director
      (William L. Weiss)


                                   II-5
<PAGE>

                               Exhibit Index
                                         

Exhibit No.   Description                                                Page

   4(a)       Restated Certificate of Incorporation of the Company,
              as amended April 24, 1987 (incorporated by reference to 
              Exhibit 3(i) to the Company's Annual Report on Form 10-K
              for the fiscal year ended December 25, 1992 ("1992 10-K")
              (File No. 1-7182)).
   4(b)       Certificate of Amendment, dated April 29, 1993, of the
              Certificate of Incorporation of the Company (incorporated
              by reference to Exhibit 3(i) to the Company's Quarterly 
              Report on Form 10-Q for the quarter ended March 26, 1993
              (File No. 1-7182)).
   4(c)       By-Laws of the Company, effective as of April 15, 1997 
              (incorporated by reference to Exhibit 3(ii) to the
              Company's Quarterly Report on Form 10-Q for the quarter 
              ended March 28, 1997 (File No. 1-7182)).
   4(d)       Form of Rights Agreement, dated as of December 16, 1987,
              between the Company and The Chase Manhattan Bank 
              (successor by merger to Manufacturers Hanover Trust
              Company) (incorporated by reference to Exhibit 3(iv) 
              to the 1992 10-K).
   4(e)       Certificate of Designation of the Company establishing
              the rights, preferences, privileges, qualifications,
              restrictions and limitations relating to the Company's
              9% Cumulative Preferred Stock, Series A (incorporated by
              reference to Exhibit 4(iii) to the Company's Quarterly
              Report on Form 10-Q for the quarter ended September 30,
              1994 (File No. 1-7182)).
   4(f)       Certificate of Designation of the Company establishing 
              the rights, preferences, privileges, qualifications, 
              restrictions and limitations relating to the Company's 
              Series A Junior Preferred Stock (incorporated by reference
              to Exhibit 3(f) to the Company's Registration Statement 
              on Form S-3 (File No. 33-19975)).
 + 5          Opinion of Counsel.
 +15          Letter re: unaudited interim financial information.
 +23(a)       Consent of Counsel (included as part of Exhibit 5).
 +23(b)       Consent of Deloitte & Touche LLP.
  24          Power of Attorney (included on Page II-4).


 + Filed herewith.


<PAGE>


                                                                     EXHIBIT 5


                            [MERRILL LYNCH LETTERHEAD]


                                          September 29, 1997


Securities and Exchange Commission
450 Fifth Street N.W.
Washington, D.C.  20549

Dear Sirs:

     I have acted as counsel for Merrill Lynch & Co., Inc., a Delaware 
corporation (the "Company"), in connection with the filing with the 
Securities and Exchange Commission on or about September 29, 1997 under the 
Securities Act of 1933, as amended, of a Registration Statement on Form S-3 
(the "Registration Statement") for the purpose of registering for resale by the
former owners of Hotchkis and Wiley L.P. (the "Selling Shareholders") 
4,600,000 shares of Common Stock, par value $1.33-1/3 per share (including 
Preferred Stock Purchase Rights) (the "Shares") which may be issued to the 
Selling Shareholders under the terms of the purchase agreement dated June 19, 
1996 pursuant to which Merrill Lynch acquired Hotchkis and Wiley in November 
1996 (the "Agreement").  In such capacity, I have examined the Restated 
Certificate of Incorporation and By-Laws of the Company, the Agreement, and 
such other documents of the Company as I have deemed necessary or appropriate 
for the purposes of the opinion expressed herein.

     Based upon the foregoing, I am of the opinion that the Shares issued 
under the Agreement will be legally issued, fully paid and nonassessable.

     We consent to the filing of this opinion as an exhibit to the 
Registration Statement and to the use of my name wherever appearing in the 
Registration Statement and any amendment thereto.


                                        Very truly yours,

                                        /s/ Richard B. Alsop
                                        -----------------------
                                        Richard B. Alsop
                                        Vice President and
                                            Senior Counsel


<PAGE>
                                                     Exhibit 15
                           [LETTERHEAD]



September 29, 1997



Merrill Lynch & Co., Inc.
World Financial Center
North Tower, 31st Floor
New York, NY 10281


We have made a review, in accordance with standards established by the 
American Institute of Certified Public Accountants, of the unaudited interim 
consolidated financial information of Merrill Lynch & Co., Inc. and 
subsidiaries as of March 28, 1997 and June 27, 1997 and for the three-month 
periods ended March 28, 1997 and March 29, 1996 and the three- and six-month 
periods ended June 27, 1997 and June 28, 1996 as indicated in our reports 
dated May 9, 1997 and August 8, 1997, respectively; because we did not 
perform an audit, we expressed no opinion on that information.

We are aware that such reports referred to above, which are included in your 
Quarterly Reports on Form 10-Q for the quarters ended March 28, 1997 and June 
27, 1997, are incorporated by reference in this Registration Statement.

We are also aware that the aforementioned report, pursuant to Rule 436(c) 
under the Securities Act of 1933, is not considered a part of the 
Registration Statement prepared or certified by an accountant or a report 
prepared or certified by an accountant within the meaning of Sections 7 and 
11 of that Act.



/s/ Deloitte & Touche LLP




<PAGE>

                                                          Exhibit 23(b)



INDEPENDENT AUDITORS' CONSENT
- -----------------------------

We consent to the incorporation by reference in this Registration Statement 
of Merrill Lynch & Co., Inc. (the "Company") on Form S-3 of our reports dated 
February 24, 1997, appearing in or incorporated by reference in the Annual 
Report on Form 10-K of the Company for the year ended December 27, 1996 and 
to the reference to us under the heading "Experts" in the Prospectus, which 
is part of this Registration Statement. We also consent to the incorporation 
by reference in this Registration Statement of our report dated February 24, 
1997, appearing as Exhibit 99(ii) in the Company's Current Report on Form 8-K 
dated March 14, 1997, relating to the Selected Financial Data under the 
captions "Operating Results", "Financial Position", and "Common Share Data" 
for each of the five years in the period ended December 27, 1996 included in 
the 1996 Annual Report to the Stockholders of the Company.



/s/ Deloitte & Touche LLP

September 29, 1997
New York, New York




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission